Skip to main content
An official website of the United States government
The SBIR and STTR programs were reauthorized on April 13, 2026. Currently, NIH has no active SBIR or STTR Notices of Funding Opportunity (NOFOs). Future NOFOs are forecasted at Grants.gov prior to opening for applications. The next standard receipt date is September 5, 2026.
Email

NCI SBIR at the 2025 Oregon Bio Conference

September 29 – September 30, 2025

Portland, Oregon

Add to Outlook Calendar

Are you attending the 2025 Oregon Bio conference from September 29-30? NCI SBIR Team Leader Jonathan Franca-Koh and Program Director Swamy Tripurani will be sharing insights on funding opportunities and commercialization resources for cancer technology innovators during the event.

On Monday, September 29, the two will participate in the "From Research to Reality: NCI SBIR/STTR Funding Pathways for Bioscience Ventures" breakout session from 2:50 - 3:50pm PDT. Dr. Franca-Koh and Dr. Tripurani will provide an overview of the NCI SBIR program, followed by presentations and lessons learned from representatives of two Oregon-based NCI SBIR-awarded companies: Trace Biosciences  and PDX Pharmaceuticals.

On Tuesday September 30, attendees can meet the NCI SBIR staff and discuss their projects during the "Lunch and Resource Roundtables (Networking event with Early-Stage Startups)" from 11:55am - 12:30pm PDT.

Email